Pharmacokinetics of losigamone

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1996

Schlagwörter:	Caffeine Clinical Pharmacology Antiepileptic Drug Clinical Chemistry Close Monitoring

Anmerkung:	© Adis International Ltd 1996

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1022(1996), 1 vom: Feb., Seite 10-10
Übergeordnetes Werk:	volume:1022 ; year:1996 ; number:1 ; month:02 ; pages:10-10

Links:	Volltext

DOI / URN:	10.2165/00128413-199610220-00014

Katalog-ID:	SPR036188204

Internformat


LEADER	01000caa a22002652 4500
001	SPR036188204
003	DE-627
005	20230519201339.0
007	cr uuu---uuuuu
008	201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199610220-00014 \|2 doi
035			\|a (DE-627)SPR036188204
035			\|a (SPR)00128413-199610220-00014-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Pharmacokinetics of losigamone
264		1	\|c 1996
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1996
650		4	\|a Caffeine \|7 (dpeaa)DE-He213
650		4	\|a Clinical Pharmacology \|7 (dpeaa)DE-He213
650		4	\|a Antiepileptic Drug \|7 (dpeaa)DE-He213
650		4	\|a Clinical Chemistry \|7 (dpeaa)DE-He213
650		4	\|a Close Monitoring \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1022(1996), 1 vom: Feb., Seite 10-10 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1022 \|g year:1996 \|g number:1 \|g month:02 \|g pages:10-10
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199610220-00014 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1022 \|j 1996 \|e 1 \|c 02 \|h 10-10

Indexfelder

matchkey_str	article:22306056:1996----::hraoieisfo
hierarchy_sort_str	1996
publishDate	1996
allfields	10.2165/00128413-199610220-00014 doi (DE-627)SPR036188204 (SPR)00128413-199610220-00014-e DE-627 ger DE-627 rakwb eng Pharmacokinetics of losigamone 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1022(1996), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1022 year:1996 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199610220-00014 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1022 1996 1 02 10-10
spelling	10.2165/00128413-199610220-00014 doi (DE-627)SPR036188204 (SPR)00128413-199610220-00014-e DE-627 ger DE-627 rakwb eng Pharmacokinetics of losigamone 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1022(1996), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1022 year:1996 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199610220-00014 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1022 1996 1 02 10-10
allfields_unstemmed	10.2165/00128413-199610220-00014 doi (DE-627)SPR036188204 (SPR)00128413-199610220-00014-e DE-627 ger DE-627 rakwb eng Pharmacokinetics of losigamone 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1022(1996), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1022 year:1996 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199610220-00014 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1022 1996 1 02 10-10
allfieldsGer	10.2165/00128413-199610220-00014 doi (DE-627)SPR036188204 (SPR)00128413-199610220-00014-e DE-627 ger DE-627 rakwb eng Pharmacokinetics of losigamone 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1022(1996), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1022 year:1996 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199610220-00014 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1022 1996 1 02 10-10
allfieldsSound	10.2165/00128413-199610220-00014 doi (DE-627)SPR036188204 (SPR)00128413-199610220-00014-e DE-627 ger DE-627 rakwb eng Pharmacokinetics of losigamone 1996 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1996 Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1022(1996), 1 vom: Feb., Seite 10-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1022 year:1996 number:1 month:02 pages:10-10 https://dx.doi.org/10.2165/00128413-199610220-00014 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1022 1996 1 02 10-10
language	English
source	Enthalten in Inpharma weekly 1022(1996), 1 vom: Feb., Seite 10-10 volume:1022 year:1996 number:1 month:02 pages:10-10
sourceStr	Enthalten in Inpharma weekly 1022(1996), 1 vom: Feb., Seite 10-10 volume:1022 year:1996 number:1 month:02 pages:10-10
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Caffeine Clinical Pharmacology Antiepileptic Drug Clinical Chemistry Close Monitoring
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1996-02-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036188204
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036188204</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519201339.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199610220-00014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036188204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199610220-00014-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacokinetics of losigamone</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1996</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Caffeine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Pharmacology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiepileptic Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Chemistry</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Close Monitoring</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1022(1996), 1 vom: Feb., Seite 10-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1022</subfield><subfield code="g">year:1996</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:10-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199610220-00014</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1022</subfield><subfield code="j">1996</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">10-10</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Pharmacokinetics of losigamone Caffeine (dpeaa)DE-He213 Clinical Pharmacology (dpeaa)DE-He213 Antiepileptic Drug (dpeaa)DE-He213 Clinical Chemistry (dpeaa)DE-He213 Close Monitoring (dpeaa)DE-He213
topic	misc Caffeine misc Clinical Pharmacology misc Antiepileptic Drug misc Clinical Chemistry misc Close Monitoring
spellingShingle	misc Caffeine misc Clinical Pharmacology misc Antiepileptic Drug misc Clinical Chemistry misc Close Monitoring Pharmacokinetics of losigamone
topic_unstemmed	misc Caffeine misc Clinical Pharmacology misc Antiepileptic Drug misc Clinical Chemistry misc Close Monitoring
topic_browse	misc Caffeine misc Clinical Pharmacology misc Antiepileptic Drug misc Clinical Chemistry misc Close Monitoring
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Pharmacokinetics of losigamone
ctrlnum	(DE-627)SPR036188204 (SPR)00128413-199610220-00014-e
title_full	Pharmacokinetics of losigamone
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1996
contenttype_str_mv	txt
container_start_page	10
container_volume	1022
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199610220-00014
title_sort	pharmacokinetics of losigamone
title_auth	Pharmacokinetics of losigamone
abstract	© Adis International Ltd 1996
abstractGer	© Adis International Ltd 1996
abstract_unstemmed	© Adis International Ltd 1996
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Pharmacokinetics of losigamone
url	https://dx.doi.org/10.2165/00128413-199610220-00014
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199610220-00014
up_date	2024-07-03T16:43:27.113Z
_version_	1803576941860618240
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036188204</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519201339.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1996 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199610220-00014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036188204</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199610220-00014-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacokinetics of losigamone</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1996</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1996</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Caffeine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Pharmacology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiepileptic Drug</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Chemistry</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Close Monitoring</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1022(1996), 1 vom: Feb., Seite 10-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1022</subfield><subfield code="g">year:1996</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:10-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199610220-00014</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1022</subfield><subfield code="j">1996</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">10-10</subfield></datafield></record></collection>
score	7.3987713

Nicht das Richtige dabei?

Schreiben Sie uns!

Pharmacokinetics of losigamone

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?